Transdermal delivery of atenolol: Effect of prodrugs and iontophoresis

Current Drug Delivery

Volumn 6, Issue 3, 2009, Pages 280-290

  Anroop, B ^a,d   Ghosh, B ^b   Parcha, V ^a   Khanam, J ^c  

^a Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

^b A Constituent Unit of KLE Academy of Higher Education Research   (India)

^c JADAVPUR UNIVERSITY   (India)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Atenolol; Iontophoresis; Prodrugs; Stability; Transdermal

Indexed keywords

ATENOLOL; ATENOLOL ACETATE; ATENOLOL BUTYRATE; ATENOLOL CAPRIATE; ATENOLOL CAPROATE; ATENOLOL PROPIONATE; ATENOLOL VALERATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; ESTERIFICATION; IONTOPHORESIS; LIPOPHILICITY; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ATENOLOL; DRUG STABILITY; ESTERS; HYDROGEN-ION CONCENTRATION; HYDROPHOBICITY; IONTOPHORESIS; PERMEABILITY; PRODRUGS; SKIN; SKIN ABSORPTION; SOLUBILITY; SUS SCROFA;

EID: 67650096770     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109788680895     Document Type: Article

References (55)

1. Barry, B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci., 2001, 14, 101-4.
2. Gordon, R.D.; Peterson, T.A. 4 myths about transdermal drug delivery. Drug Del. Tech., 2003, 3, 1-12.
3. Gary, P.M.; Darren, R.G.; Paul, A.C.; Cameron, A.; Matthew, J.I.; John, D.S.; John, P.W. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption. J. Pharm. Pharmacol., 2006, 58, 167-77.
4. Ahmed, S.; Imai, T.; Otagiri, M. Stereo selective hydrolysis and penetration of propranolol prodrugs: In vitro evaluation using hairless mouse skin J. Pharm. Sci., 1995, 84, 877-83.
5. Valiveti, S., Hammel, D.C.; Paudel, K.S.; Hamad, M.O.; Crooks, P.A.; Stinchcomb, A.L. In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs. J. Control. Release, 2005, 102, 509-20.
6. Stinchcomb, A.L.; Swaan, P.W.; Ekabo, O.; Harris, K.K.; Browe, J.; Hammell, D.C.; Cooperman, T.A.; Pearsall, M. Straight chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. J. Pharm. Sci., 2002, 91, 2571-8.
7. Vaddi, H.K.; Hamad, M.O.; Chen, J.; Banks, S.L.; Crooks, P.A.; Stinchcomb, A.L. Human skin permeation of branched-chain 3-Oalkyl esters and carbonate prodrugs of naltrexone. Pharm. Res., 2005, 22, 758-65.
8. Delgado- Charro, M.B.; Guy, R.H. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. S.T.P. Pharma. Sci., 2001, 11, 403-14.
9. Aqil, M.; Sultana, Y.; Ali, A. Transdermal delivery of betablockers. Expert Opin. Drug Deliv., 2006, 3, 405-18.
10. th ed., McGraw -Hill Co.: New York, 1996; pp. 199-248.
11. Demou, J.S.; Sidhom, M.B.; Plakogiannis, F.M. Comparative in vitro diffusion studies for atenolol transdermal delivery system. Pharm. Acta. Helv., 1994, 68, 215-9.
12. Cho, C.W.; Shin, S.C. Enhanced transdermal delivery of atenolol from the ethylene vinyl acetate matrix. Int. J. Pharm., 2004, 287, 67-71.
13. Gupta, J.; Jain, S. Development of matrix membrane transdermal drug delivery system for atenolol. Drug Deliv., 2004, 11, 281-6.
14. Dennet, A.; Ucakar, B.; Preta, V. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: A mechanistic approach. Pharm. Res., 2003, 20, 12-8.
15. Reddy, L.H.; Ghosh, B., Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin. Indian J. Exp. Biol., 2001, 39, 47-51.
16. Alexander, J.; Cargill, R.; Michelson, S.R.; Schwam, H. Acyloxy alkyl carbamates as novel bioreversible prodrugs for amines: Increased permeation through biological membranes. J. Med. Chem., 1998, 31, 319-22.
17. Hardman, J.G.; Limbird, L.E. Goodman and Gilman's The pharmacological basis of therapeutics, McGraw -Hill, New York, 1996.
18. Ghosh, B.; Reddy, L.H. Effect of physiochemical parameters on the skin permeability of antihypertensive. Indian J. Exp. Biol., 2001, 39, 710-4.
19. Anroop, B.; Ghosh, B.; Parcha, V.; Kumar, A.; Khanam, J. Synthesis and comparative skin permeability of atenolol and propranolol esters. J. Drug Del. Sci. Tech., 2005, 15, 187-90.
20. Caplar, V.; Mihun, Z.M.; Hofman, H.; Kuftinec, J.; Kajfez, F.; Nagl, A,; Blazevic, N. In Analytical profiles of drug substances, Florey, K., Ed.; Academic Press: New York, 1984, Vol. 13, pp 1-25.
21. Sasaki, H.; Igarashi, Y.; Nagano, T.; Nishida, K.; Nakamura, Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. J. Pharm. Res., 1995, 12, 1146-50.
22. Modamio, P.; Lastra, C.F.; Marino, E.L. A comparative in vitro study of percutaneous preparations of β-blockers in human skin. Int. J. Pharm., 2000, 194, 249-59.
23. Okumara, M.; Sugibayashi, K.; Ogawa, K.; Morimoto, Y. Skin permeability of water soluble drugs. Chem. Pharm. Bull., 1989, 37, 1404-9.
24. Kim, B.Y.; Doh, H.J.; Le, T.N.; Cho, W.J.; Yong, C.S.; Choi, H.G.; Kim, J.S.; Lee, C.H.; Kim, D.D. Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies. Int. J. Pharm., 2005, 293, 193-202.
25. Banga, A.K. Electrically assisted transdermal and topical drug delivery, Taylor and Francis: Bristol, 1998.
26. Cullander, C. What are the pathways of iontophoresis current flow through mammalian skin. Adv. Drug Del. Rev., 1992, 9, 119-35.
27. Slough, C.L.; Spinelli, M.J.; Kasting, G.B. Transdermal delivery of etidronate in the pig via iontophoresis. J. Memb. Sci., 1998, 35, 161-5.
28. Moser, K.; Kriwet, K.; Naik, A.; Kalia, Y.N.; Guy, R.H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm., 2001, 52, 103-12.
29. Langkjaer, L.; Brange, J.; Grodsky, G.M.; Guy, R.H. Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment. J. Control. Release, 1998, 51, 47-56.
30. Bonina, F.P.; Rimoli, M.G.; Avallone, L.; Barbato, F.; Amato, M.; Puglia, C.; Ricci, M.; De-Caprariis, P. New oligoethylene ester derivatives of 5-iodo-2′-deoxyuridine as dermal prodrugs: synthesis, physicochemical properties, and skin permeation studies. J. Pharm. Sci., 2002, 91, 171-9.
31. Waranis, R.P.; Sloan, K.B. Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci., 1987, 76, 587-95.
32. Doh, H.J.; Cho, W.J.; Yong, C.S.; Choi, H.G.; Kim, J.S.; Lee, C.H.; Kim, D.D. Synthesis and evaluation of ketorolac ester prodrugs for transdermal delivery. J. Pharm. Sci., 2003, 92, 1008-17.
33. Diez, I.; Colom, H.; Moreno, J.; Obach, R,; Peraire, C; Domenech, J. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 1991, 80, 931-4.
34. Wang, W.; Sasaki, H.; Chien, D.S.; Lee, V.H. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr. Eye Res., 1991, 10, 571-9.
35. Le Brun, P.P.H.; Fox, P.L.A.; de Vries, M.E.; Bodde, H.E. In vitro penetration of some β-adrenoreceptor blocking drugs through porcine buccal mucosa. Int. J. Pharm., 1989, 49, 141-5.
36. Ghosh, T.K.; Chiao, C.S.; Gokhale, R.D. In-vitro permeation of some β-blockers across the hairless mouse skin. J. Pharm. Pharmacol., 1993, 45, 218-9.
37. Schoenwald, R.D.; Huang, H.S. Corneal penetration behaviour of β-blocking agents I: physicochemical factors. J. Pharm. Sci., 1983, 112, 1266-71.
38. Ahmed, S.; Imai, T.; Yoshigae, Y.; Otagiri, M. Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma. Life Sci., 1997, 61, 1879-87.
39. Ostacolo, C.; Marra, F.; Laneri, S.; Sacchi, A.; Nicoli, S.; Padula, C.; Santi, P. Alpha-tocopherol pro-vitamins: synthesis, hydrolysis and accumulation in rabbit ear skin. J. Control Release, 2004, 99, 403-13.
40. Sung, K.C.; Fang, J.Y.; Hu, O.Y. Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis. J. Control Release, 2000, 67, 1-8.
41. Rautio, J.; Taipale, H.; Gynther, J.; Vepsalainen, J.; Nevalainen, T.; Jarvinen, T. In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. J. Pharm. Sci., 1998, 87, 1622-8.
42. Turner, N.G.; Guy, R.H. Iontophoretic transport pathways: Dependence on penetrant physicochemical properties. J. Pharm. Sci., 1997, 86, 1385-9.
43. Huang, J.F.; Sung, K.C.; Hu, O.Y.P ; Wang, J.J.; Lin, Y.H.; Fang, J.Y. The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int. J. Pharm., 2005, 297, 162-71.
44. Panchagnula, R.; Bokalial, R.; Sharma, P.; Khandavilli, S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int. J. Pharm., 2005, 293, 213-3.
45. Lipp, R.; Laurent, H.; Gunther, C.; Riedl, J.; Esperling, P.; Tauber, U. Prodrugs of gestodene for matrix-type transdermal drug delivery systems. Pharm. Res., 1998, 15, 1419-24.
46. Chien, Y.W. Transdermal controlled systemic medications, Marcel Dekker, Inc.: New York and Basel, 1987.
47. Guy, R.H. Iontophoresis - recent developments. J. Pharm. Pharmacol., 1998, 50, 371-4.
48. Merino, V.; Kalia, Y.N.; Guy, R.H. Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol., 1997, 15, 288-90.
49. Turner, N.G.; Guy, R.H. Iontophoretic transport pathways: Dependence on penetrant physicochemical properties. J. Pharm. Sci., 1997, 86, 1385-9.
50. Boxtel, A.V. Skin resistance during square-wave electrical pulses of 1 to 10 mA. Med. Biol. Eng. Comput. 1997, 15, 679-87.
51. Guy, R.H.; Kalia, Y.N.; Delgado-Charro, M.B.; Merino, V.; Lopez, A.; Marro, D. Iontophoresis: electrorepulsion and electroosmosis. J. Control Release, 2000, 64, 129-32.
52. Singh, S.; Singh, Transdermal drug delivery by passive diffusion and iontophoresis: a review. J. Med. Res. Rev., 1993, 5, 569-621.
53. Phipps, J.B.; Gyory, J.R. Transdermal ion migration. Adv. Drug Deliv. Rev., 1990, 9, 137-76.
54. Pillai, O.; Panchagnula, R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J. Control Release, 2003, 89, 127-40.
55. Merino, V.; Opez, A.; Kalia, Y.N.; Guy, R.H. Electrorepulsion versus electroosmosis: Effect of pH on the iontophoretic flux of 5-Fluorouracil. Pharm. Res., 1999, 16, 758-61.